Bubs Australia announced Dennis Lin has become executive chairman of the infant-formula manufacturer with a remit to drive the company’s China strategy.
Lin joined Sydney-listed Bubs’ board in January 2017 and was appointed non-executive chairman later that year. As as trained chartered accountant and solicitor, he has specialised in commercial transactions, mergers and acquisitions, and capital-market activities between Chinese and Australian businesses, with a focus on the agriculture and consumer goods sectors.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Kristy Carr, Bub’s chief executive and executive director, said: “The board is unanimous in supporting this appointment of Dennis as executive chair as it secures Dennis’ instrumental skill set for the company and closely aligns his role with our future performance. Dennis has been the architect behind our approach to mergers and acquisitions, and the formation of our strategic partnerships. Our China business has grown significantly thanks to his input and we expect it will continue to do so.
“Under his new executive role, Dennis will be more actively involved in driving our China strategy and I look forward to continuing to work in close partnership with him.”
Bubs specialises in goat’s milk infant formulas, but also offers the cow’s milk variety, along with rusks, cereals, and vegetable and fruit-based snacks.
It has a focus on China, where it inked a deal in June with baby products retailer Kidswant via its joint venture, Bubs Brand Management Shanghai Co., which was formed in March with China’s Beingmate Baby & Child Food Co. In April, Bubs entered an alliance with local pharmacy retailer Chemist Warehouse, which has e-commerce links with China.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAnd the infant-formula maker earlier acquired Deloraine Dairy which is approved to ship baby formula to China. Last year, Bubs formed a deal with online distributor Hipac, building on its existing network in China that includes a merchandise agreement with Alibaba and distribution agreements with New Times Asia and on-line platform JD.com.
